{
  "module": "Musculoskeletal_Pharm",
  "questions": [
    {
      "id": "MUSC_1",
      "stem": "The nurse provides teaching to a patient who will begin taking cyclobenzaprine to treat acute muscle spasms. Which statement by the patient indicates a need for further teaching?",
      "options": [
        "\"I may experience dizziness and drowsiness when I take this drug.\"",
        "\"I should not consume alcohol while taking this medication.\"",
        "\"I should be careful driving with this medication because it can cause drowsiness.\"",
        "\"I will take this medication for 3 months and then stop taking it.\""
      ],
      "correct": [
        "D"
      ],
      "rationale": "Most centrally acting muscle relaxants used for acute spasms are taken for no longer than 3 weeks and should be tapered over 1 week to avoid rebound spasms. Patients may experience dizziness and drowsiness. Alcohol will compound the central nervous system sedative effects. Patients should be cautioned about driving and operating machinery while using muscle relaxants.",
      "type": "single_select"
    },
    {
      "id": "MUSC_2",
      "stem": "Which agent listed below is used in surgery to achieve neuromuscular blockade and paralysis?",
      "options": [
        "Baclofen",
        "Chlorzoxazone",
        "Pancuronium bromide",
        "Methocarbamol"
      ],
      "correct": [
        "C"
      ],
      "rationale": "Pancuronium bromide is used as a muscle relaxant as adjunct to anesthesia. Baclofen is used for muscle spasms caused by MS or spinal cord injury. Chlorzoxazone and methocarbamol are used for acute muscle spasms.",
      "type": "single_select"
    },
    {
      "id": "MUSC_3",
      "stem": "The nurse is teaching a patient about taking colchicine to treat gout. What information will the nurse include when teaching this patient about this drug?",
      "options": [
        "Avoid all alcohol except beer.",
        "Include salmon in the diet.",
        "Increase fluid intake.",
        "Take on an empty stomach."
      ],
      "correct": [
        "C"
      ],
      "rationale": "The patient who is taking colchicine (and other antigout agents) should increase fluid intake to promote uric acid excretion and prevent renal calculi. Foods rich in purine should be avoided, including beer, and some sea foods, such as salmon. Gastric irritation is a common problem, so colchicine should be taken with food.",
      "type": "single_select"
    },
    {
      "id": "MUSC_4",
      "stem": "The nurse is caring for a patient who is receiving a third dose of high-dose cyclophosphamide. The nurse notes hematuria. The nurse will notify the provider and will perform which action?",
      "options": [
        "Ask whether the patient takes allopurinol.",
        "Assess the patient's skin and fingernails for darkening.",
        "Question the patient about fluid intake.",
        "Reassure the patient that this is an expected side effect."
      ],
      "correct": [
        "C"
      ],
      "rationale": "Hemorrhagic cystitis is a common adverse effect of high-dose cyclophosphamide and can be mitigated by increasing fluid intake. Allopurinol is given to treat gout, which is characterized by uric acid crystalluria. Darkening of the fingernails and skin is a common adverse effect of cyclophosphamide but is unrelated to hemorrhagic cystitis.",
      "type": "single_select"
    },
    {
      "id": "MUSC_5",
      "stem": "Which antigout medication is considered first-line to treat chronic tophaceous gout?",
      "options": [
        "Allopurinol",
        "Colchicine",
        "Probenecid",
        "Celecoxib"
      ],
      "correct": [
        "A"
      ],
      "rationale": "Allopurinol inhibits the biosynthesis of uric acid and is used long-term to manage chronic gout and is considered the drug of choice for chronic tophaceous gout. Colchicine does not inhibit uric acid synthesis or promote uric acid secretion and is not used for chronic gout. Probenecid can be used for chronic gout but is not the first choice. Celecoxib is a COX-2 selective antiinflammatory and does not have a role in treating chronic tophaceous gout.",
      "type": "single_select"
    },
    {
      "id": "MUSC_6",
      "stem": "A patient who has psoriasis will begin taking etanercept (Enbrel). The nurse will ensure that which laboratory test is performed prior to initiating treatment with this drug?",
      "options": [
        "Complete blood count (CBC) with differential",
        "CD4 and T-cell count",
        "Serum pregnancy test",
        "Tuberculin skin test"
      ],
      "correct": [
        "D"
      ],
      "rationale": "Etanercept can worsen infections by suppressing the immune system, and patients taking this drug must have a tuberculin skin test prior to initiation of treatment. CBC, CD4, and T-cell counts may be monitored during therapy. A serum pregnancy test is not specifically indicated prior to use.",
      "type": "single_select"
    },
    {
      "id": "MUSC_7",
      "stem": "The nurse provides teaching for a patient who will begin taking indomethacin to treat symptoms of rheumatoid arthritis. Which statement by the patient indicates a need for further teaching?",
      "options": [
        "\"I should avoid this medication if I am allergic to aspirin.\"",
        "\"I should take indomethacin on an empty stomach.\"",
        "\"I should not take this in combination with other over-the-counter NSAIDs.\"",
        "\"I will take the medication twice daily.\""
      ],
      "correct": [
        "B"
      ],
      "rationale": "Indomethacin is very irritating to the stomach and should be taken with food. The medication is taken twice daily. Indomethacin is not recommend for use in patients who are allergic to aspirin, and should not be used in combination with OTC NSAID products to avoid duplication.",
      "type": "single_select"
    },
    {
      "id": "MUSC_8",
      "stem": "The nurse is caring for a patient who has rheumatoid arthritis and who is receiving infliximab IV every 8 weeks. Which laboratory test will the nurse anticipate that this patient will need?",
      "options": [
        "Calcium level",
        "Complete blood count",
        "Electrolytes",
        "Potassium"
      ],
      "correct": [
        "B"
      ],
      "rationale": "Infliximab is an immunomodulator and can cause agranulocytosis, so patients should have regular CBC monitoring.",
      "type": "single_select"
    },
    {
      "id": "MUSC_9",
      "stem": "The nurse is performing an admission assessment on a patient who has been taking carisoprodol for 3 weeks to treat muscle spasms. The patient reports that the muscle spasms have resolved. The nurse will contact the provider to discuss",
      "options": [
        "changing to cyclobenzaprine.",
        "continuing the carisoprodol for 1 more week.",
        "discontinuing the carisoprodol now.",
        "ordering a taper of the carisoprodol."
      ],
      "correct": [
        "D"
      ],
      "rationale": "Muscle relaxants can result in drug dependence and should not be withdrawn abruptly. The nurse should discuss a drug taper. Changing to a different muscle relaxant (cyclobenzaprine) is not recommended since the patient is doing well.",
      "type": "single_select"
    },
    {
      "id": "MUSC_10",
      "stem": "A patient who takes high-dose aspirin to treat rheumatoid arthritis has a serum salicylate level of 35 mg/dL. The nurse will perform which action?",
      "options": [
        "Assess the patient for signs of toxicity, such as tinnitus.",
        "Monitor the patient for signs of Reye's syndrome.",
        "Notify the provider of severe aspirin toxicity.",
        "Request an order for an increased aspirin dose."
      ],
      "correct": [
        "A"
      ],
      "rationale": "Mild toxicity occurs at levels above 30 mg/dL, so the nurse should assess for signs of toxicity, such as tinnitus. This level will not increase the risk for Reye's syndrome. Severe toxicity occurs at levels greater than 50 mg/dL. The dose should not be increased.",
      "type": "single_select"
    },
    {
      "id": "MUSC_11",
      "stem": "The nurse is assessing a patient who has gout who will begin taking allopurinol. The nurse reviews the patient's medical record and will be concerned about which of the following findings?",
      "options": [
        "History of kidney stones",
        "Increased serum uric acid",
        "Slight increase in the white blood count",
        "Increased serum glucose"
      ],
      "correct": [
        "A"
      ],
      "rationale": "Allopurinol use can increase the risk of kidney stones resulting from uric acid secretion. This can be prevented by increasing water intake and maintaining a urine pH above 6. A history of kidney stones would not be a contraindication to allopurinol use, but additional caution and patient teaching to prevent kidney stone formation is warranted.",
      "type": "single_select"
    },
    {
      "id": "MUSC_12",
      "stem": "Which of the following DMARD medications is an IL-1 receptor antagonist?",
      "options": [
        "Etanercept",
        "Anakinra",
        "Infliximab",
        "Rituximab"
      ],
      "correct": [
        "B"
      ],
      "rationale": "Anakinra is a DMARD that works via antagonism of IL-1 receptors. Etanercept and infliximab are TNF inhibitors. Rituximab induces cell lysis of B cells. All of these agents are indicated to treat rheumatoid arthritis.",
      "type": "single_select"
    }
  ]
}